Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Asker Healthcare Group AB ( (SE:ASKER) ) has issued an update.
Asker Healthcare Group, a European provider of medical products and solutions to healthcare systems, operates through a network of entrepreneurial local companies backed by the scale and expertise of a larger group. With more than 4,500 employees in 19 countries and SEK 17 billion in revenue, it focuses on enhancing patient outcomes while driving cost efficiency and sustainability across the healthcare value chain.
The company has released its Annual and Sustainability Report for 2025, highlighting a 17% increase in adjusted EBITA and sustained high activity during the year. Asker underscored its successful Nasdaq Stockholm listing, execution of its twin-engine strategy of organic growth and acquisitions, and the completion of 14 acquisitions with entry into four new countries, reinforcing its leading European position and signalling continued expansion and commitment to a more sustainable healthcare system.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK120.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients by providing medical products and solutions across 19 countries. The group builds and acquires leading local companies to improve patient outcomes, lower the total cost of care, and promote a fair and sustainable value chain, generating SEK 17 billion in revenue with more than 4,500 employees.
Average Trading Volume: 550,477
Technical Sentiment Signal: Buy
Current Market Cap: SEK29.16B
Find detailed analytics on ASKER stock on TipRanks’ Stock Analysis page.